This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_OROPHARYNG_EXALLC for full statistics.
Malignant neoplasm of oropharynx
C3_OROPHARYNG
oropharynx cancer: A primary or metastatic malignant neoplasm that affects the oropharynx.
Endpoint definition
↥
FinnGen phenotype data
392423 individuals
Apply sex-specific rule None
392423
Check conditions None
392423
Check pre-conditions, main-only, mode, registry filters
Cause of death: ICD-10
C10
Cause of death: ICD-9
146
Cause of death: ICD-8
146
Cause of death: excluded ICD-9
1460A
Cancer registry: Topography ICD-O-3
C10
Cancer registry: Morphology ICD-O-3
ANY
Cancer registry: Behaviour codes
3
2 out of 7 registries used, show all original rules.
27
Check minimum number of events None
27
Include endpoints None
27
Remove individuals based on genotype QC
27
C3_OROPHARYNG
Control definitions
Controls for this endpoint are individuals that are not cases.
Extra metadata
Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF9
Not enough data for upset plot.
Or the full data table
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of oropharynx
based on the number of shared cases.
Broader endpoints:
- Malignant neoplasm of oropharynx (controls excluding all cancers)
- Malignant neoplasm of oropharynx (controls excluding all cancers)
- Malignant neoplasm of oropharynx
- Malignant neoplasm of head and neck
- Malignant neoplasm of head and neck (controls excluding all cancers)
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 27 | 5 | 22 |
| Unadjusted prevalence (%) | 0.01 | 0.00 | 0.01 |
| Mean age at first event (years) | 64.24 | 63.02 | 64.52 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: C3_OROPHARYNG – Malignant neoplasm of oropharynx
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Malignant neoplasm of oropharynx
↥Endpoint not on priority list, no data to show.